Cargando…

Surgery including fertility-sparing treatment of GTD

Gestational trophoblastic disease (GTD) consists of a spectrum of diseases, including hydatidiform moles, invasive mole, metastatic mole, choriocarcinoma, placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). GTD is a relatively uncommon disease occurring in women of...

Descripción completa

Detalles Bibliográficos
Autores principales: Ngu, Siew-Fei, Ngan, Hextan Y.S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Published by Elsevier Ltd. 2021
Materias:
7
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547826/
https://www.ncbi.nlm.nih.gov/pubmed/33127305
http://dx.doi.org/10.1016/j.bpobgyn.2020.10.005
_version_ 1783592502773678080
author Ngu, Siew-Fei
Ngan, Hextan Y.S.
author_facet Ngu, Siew-Fei
Ngan, Hextan Y.S.
author_sort Ngu, Siew-Fei
collection PubMed
description Gestational trophoblastic disease (GTD) consists of a spectrum of diseases, including hydatidiform moles, invasive mole, metastatic mole, choriocarcinoma, placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). GTD is a relatively uncommon disease occurring in women of reproductive age, with high cure rates. Primary treatment of hydatidiform moles includes uterine evacuation, followed by close monitoring of serial hCG levels to detect for post-molar gestational trophoblastic neoplasia (GTN). In patients with GTN, the main therapy consists of chemotherapy, although some surgical procedures are important in selected patients to achieve curing. Hysterectomy is the mainstay treatment for PSTT or ETT and may be considered in selected patients for management of hydatidiform mole and malignant GTN especially in chemoresistant disease. Resection of metastatic lesions such as in the lung or brain can be considered in selected patients with isolated chemoresistant tumour. Surgical treatment of GTD will be discussed in this chapter.
format Online
Article
Text
id pubmed-7547826
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Published by Elsevier Ltd.
record_format MEDLINE/PubMed
spelling pubmed-75478262020-10-13 Surgery including fertility-sparing treatment of GTD Ngu, Siew-Fei Ngan, Hextan Y.S. Best Pract Res Clin Obstet Gynaecol 7 Gestational trophoblastic disease (GTD) consists of a spectrum of diseases, including hydatidiform moles, invasive mole, metastatic mole, choriocarcinoma, placental site trophoblastic tumour (PSTT) and epithelioid trophoblastic tumour (ETT). GTD is a relatively uncommon disease occurring in women of reproductive age, with high cure rates. Primary treatment of hydatidiform moles includes uterine evacuation, followed by close monitoring of serial hCG levels to detect for post-molar gestational trophoblastic neoplasia (GTN). In patients with GTN, the main therapy consists of chemotherapy, although some surgical procedures are important in selected patients to achieve curing. Hysterectomy is the mainstay treatment for PSTT or ETT and may be considered in selected patients for management of hydatidiform mole and malignant GTN especially in chemoresistant disease. Resection of metastatic lesions such as in the lung or brain can be considered in selected patients with isolated chemoresistant tumour. Surgical treatment of GTD will be discussed in this chapter. Published by Elsevier Ltd. 2021-07 2020-10-10 /pmc/articles/PMC7547826/ /pubmed/33127305 http://dx.doi.org/10.1016/j.bpobgyn.2020.10.005 Text en © 2020 Published by Elsevier Ltd. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle 7
Ngu, Siew-Fei
Ngan, Hextan Y.S.
Surgery including fertility-sparing treatment of GTD
title Surgery including fertility-sparing treatment of GTD
title_full Surgery including fertility-sparing treatment of GTD
title_fullStr Surgery including fertility-sparing treatment of GTD
title_full_unstemmed Surgery including fertility-sparing treatment of GTD
title_short Surgery including fertility-sparing treatment of GTD
title_sort surgery including fertility-sparing treatment of gtd
topic 7
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7547826/
https://www.ncbi.nlm.nih.gov/pubmed/33127305
http://dx.doi.org/10.1016/j.bpobgyn.2020.10.005
work_keys_str_mv AT ngusiewfei surgeryincludingfertilitysparingtreatmentofgtd
AT nganhextanys surgeryincludingfertilitysparingtreatmentofgtd